Rolf Steffensen

4.0k total citations
62 papers, 2.7k citations indexed

About

Rolf Steffensen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rolf Steffensen has authored 62 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 23 papers in Surgery and 22 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rolf Steffensen's work include Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers) and Cardiac Imaging and Diagnostics (15 papers). Rolf Steffensen is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers) and Cardiac Imaging and Diagnostics (15 papers). Rolf Steffensen collaborates with scholars based in Denmark, United States and Singapore. Rolf Steffensen's co-authors include Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Gorm Boje Jensen, Charlotte Kragelund, Lars Køber, Per Hildebrandt, Peter Schnohr, Bjørn Grønning, Birgit Agerholm-Larsen and Gorm Jensen and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Rolf Steffensen

62 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rolf Steffensen Denmark 26 1.4k 1.1k 938 340 308 62 2.7k
Tetsuya Babazono Japan 33 649 0.5× 510 0.5× 1.2k 1.2× 632 1.9× 315 1.0× 143 3.3k
Sylvain Ricard France 21 2.3k 1.6× 686 0.6× 1.8k 2.0× 847 2.5× 690 2.2× 31 4.0k
Hideo Izawa Japan 33 2.0k 1.4× 1.0k 1.0× 568 0.6× 933 2.7× 200 0.6× 183 4.0k
Carlos G. Santos‐Gallego United States 34 1.6k 1.1× 1.1k 1.1× 1.4k 1.4× 959 2.8× 102 0.3× 97 3.2k
Stephan Holmer Germany 29 2.1k 1.5× 452 0.4× 952 1.0× 711 2.1× 359 1.2× 80 3.2k
Amy E. Rudolph United States 25 830 0.6× 887 0.8× 961 1.0× 473 1.4× 94 0.3× 40 2.3k
Sally M. Marshall United Kingdom 33 841 0.6× 637 0.6× 1.4k 1.5× 532 1.6× 536 1.7× 93 3.3k
Winfried Maerz Germany 22 704 0.5× 519 0.5× 438 0.5× 387 1.1× 136 0.4× 45 1.9k
Toshifumi Mannami Japan 28 859 0.6× 415 0.4× 671 0.7× 403 1.2× 175 0.6× 46 2.2k
James P. Pirruccello United States 23 722 0.5× 477 0.5× 282 0.3× 359 1.1× 238 0.8× 62 1.9k

Countries citing papers authored by Rolf Steffensen

Since Specialization
Citations

This map shows the geographic impact of Rolf Steffensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Steffensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Steffensen more than expected).

Fields of papers citing papers by Rolf Steffensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Steffensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Steffensen. The network helps show where Rolf Steffensen may publish in the future.

Co-authorship network of co-authors of Rolf Steffensen

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Steffensen. A scholar is included among the top collaborators of Rolf Steffensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Steffensen. Rolf Steffensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mygind, Naja Dam, Anna Axelsson Raja, Martin H. Ruwald, et al.. (2016). The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test. PubMed. 5(1). 21–27. 4 indexed citations
2.
Schønemann‐Lund, Martin, Mikkel Malby Schoos, Kasper Iversen, et al.. (2015). Retrospective Evaluation of Two Fast-track Strategies to Rule Out Acute Coronary Syndrome in a Real-life Chest Pain Population. Journal of Emergency Medicine. 49(6). 833–842. 2 indexed citations
3.
Juul‐Kristensen, Birgit, Inge Ris, Rigmor Jensen, et al.. (2013). Increased neck muscle activity and impaired balance among females with whiplash-related chronic neck pain: A cross-sectional study. Journal of Rehabilitation Medicine. 45(4). 376–384. 47 indexed citations
4.
Schoos, Mikkel Malby, Martin L. Nielsen, Steen Ingemann Hansen, et al.. (2013). HIGH-SENSITVITY CARDIAC TROPONINS, COPEPTIN AND HEART-TYPE FATTY ACID-BINDING PROTEIN IN A SINGLE SAMPLE MULTI-MARKER APPROACH AT ADMISSION FOR THE DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 61(10). E189–E189. 1 indexed citations
5.
Schoos, Mikkel Malby, J. Thode, Steen Werner Hansen, et al.. (2013). USEFULNESS OF CREATINE-KINASE MYOCARDIAL BAND IN THE DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION AFTER THE ADVENT OF HIGH-SENSITIVITY CARDIAC TROPONINS. Journal of the American College of Cardiology. 61(10). E239–E239. 1 indexed citations
6.
Eldrup, Nikolaj, Charlotte Kragelund, Rolf Steffensen, & Børge G. Nordestgaard. (2010). Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up. Nutrition Metabolism and Cardiovascular Diseases. 22(8). 677–683. 11 indexed citations
7.
Weischer, Maren, Klaus Juul, Jeppe Zacho, et al.. (2009). Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population. Atherosclerosis. 208(2). 480–483. 25 indexed citations
8.
Frikke‐Schmidt, Ruth, Charles F. Sing, Børge G. Nordestgaard, Rolf Steffensen, & Anne Tybjærg‐Hansen. (2006). Subsets of SNPs define rare genotype classes that predict ischemic heart disease. Human Genetics. 120(6). 865–877. 13 indexed citations
9.
Kragelund, Charlotte, Bjørn Grønning, Torbjørn Omland, et al.. (2006). Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?. American Heart Journal. 151(3). 712.e1–712.e7. 26 indexed citations
10.
Kragelund, Charlotte, Bjørn Grønning, Lars Køber, Per Hildebrandt, & Rolf Steffensen. (2005). N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease. New England Journal of Medicine. 352(7). 666–675. 491 indexed citations
11.
Frikke‐Schmidt, Ruth, Børge G. Nordestgaard, Peter Schnohr, Rolf Steffensen, & Anne Tybjærg‐Hansen. (2005). Mutation in ABCA1Predicted Risk of Ischemic Heart Disease in the Copenhagen City Heart Study Population. Journal of the American College of Cardiology. 46(8). 1516–1520. 48 indexed citations
12.
Jacobsen, Michael Dilou, Galen S. Wagner, Lene Holmvang, et al.. (2004). Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population. European Heart Journal. 26(2). 112–118. 17 indexed citations
13.
Kjøller‐Hansen, Lars, Jens J. Thiis, Rolf Steffensen, & Peer Grande. (2003). Add-On Benefit to Coronary Artery Bypass Grafting of Treatment with Ramipril for Major Cardiac Events and Left Ventricular Remodeling in Intermediate-Risk Patients. 3(2). 73–81. 1 indexed citations
14.
Andersen, Rolf V., Hans H. Wittrup, Anne Tybjærg‐Hansen, et al.. (2003). Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease. Journal of the American College of Cardiology. 41(11). 1972–1982. 104 indexed citations
16.
Frikke‐Schmidt, Ruth, Anne Tybjærg‐Hansen, Rolf Steffensen, Gorm Jensen, & Børge G. Nordestgaard. (2000). Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease. Journal of the American College of Cardiology. 35(5). 1192–1199. 59 indexed citations
17.
Wittrup, Hans H., et al.. (1997). A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.. Journal of Clinical Investigation. 99(7). 1606–1613. 104 indexed citations
18.
Vestergaard, Henrik, P. Skøtt, Rolf Steffensen, et al.. (1995). Insulin-resistant glucose metabolism in patients with microvascular angina—syndrome X. Metabolism. 44(7). 876–882. 5 indexed citations
19.
Steffensen, Rolf, Peer Grande, Flemming Pedersen, & Stig Haunsø. (1993). Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia. International Journal of Cardiology. 40(2). 143–153. 14 indexed citations
20.
Steffensen, Rolf, et al.. (1991). Arachidonic Acid-induced Platelet Aggregation ex vivo in Patients with Acute Ischaemic Heart Disease. Platelets. 2(1). 25–30. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026